NAVBO members receive discounts on registration to IVBM 2016
|
|
|
| Look inside the IVBM Virtual Conference Bag |
|
Lymphatic Forum
in Chicago, IL
June 8-10, 2017
Vascular Biology 2017
Monterey, CA
October 15-19
|
Diamond Level
Welcome Reception Host
|
|
Gold Level
Academic Supporter
 |
|
Silver Level
Academic Supporters
|
|
|
|
Bronze Level
Academic Supporters
|
|
|
|
Special IVBM Group Rate at the Sheraton Boston Hotel
|
Make your reservations by October 8 to secure the group rate
NAVBO has contracted the special group rate of $275 a night for IVBM attendees. The $275 a night is for single or double occupancy (triple is $315, quad is $355).
This group rate is only available through October 8.
Booking at the host hotel helps NAVBO meet its commitment to the hotel and makes for a more comfortable and convenient stay for you.
Additional information about child care, traveling around Boston, and additional offsite rooms at the Midtown Hotel can be found here:
19th International Vascular Biology Meeting
Boston - October 30-November 3
Register online through October 28
(onsite registration will be available, late fee will apply)
Hotel reservations - October 8
|
|
Industry News - Exhibitor Showcases at the IVBM
|
Exhibitor Showcases at the IVBM - Boston
Monday, October 31 from 5:15-6:15pm
Protocols for Measuring Endothelial Barrier Function with ECIS
(from TEER across transwell filters to large scale screens on 96 well plates)
Presentation by Dr. Christian Renken, Applied BioPhysics
Wednesday, November 2 from 4:00-5:00pm
Monday, October 31 from 4:00-5:00pm
Targeted proteomics performed on the Q Exactive permits to study the metabolism of circulating apolipoproteins
Sasha A. Singh, Director of Proteomics Center for Interdisciplinary Cardiovascular Sciences Brigham and Women's Hospital, Boston, MA
Translational Proteomics Workflows for Extending the Profiling Range of Plasma/Serum
Scott Peterman and David Sarracino Thermo Fisher Scientific BRIMS, Cambridge, MA
Tuesday, November 1 from 4:00-5:00pm
Unlocking Translational Biomarkers in Vascular Biology with Ultra High Frequency Ultrasound
Presentation by Dr. Julius Decano, Brigham and Women's Hospital
|
|
Welcome our new members:
Colette Bichsel, Boston Children's Hospital / Harvard Medical School
Matthew Hagen, Oregon Health & Science University
Frederik Kloss, Hannover Medical School
John Mably, Hampton University
Marwa Mahmoud, Emory University
Keri Schadler, MD Anderson Cancer Center
Hua Zhang, University of North Carolina
|
|
Spotlight on Trainees
(from Sept 1 issue)
|
Too Funny or Too Real?
Users of Facebook likely have already encountered shares of the droll
tableaux constructed of Lego minifigures and lampooning various aspects of graduate school life. Few aspects of the trainee experience are spared satirical barbs: targeted are the major professor's capricious directives, the student's need for extreme economy when socializing or traveling to meetings, and the vulnerability of all to the vagaries of audiovisual technology. Even at a distance of nearly 30 years from his graduate school days, your faithful editor still wonders whether it is too soon to find the vignettes altogether amusing without tiny beads of sweat forming on his forehead.
|
|
Recent Publications by NAVBO Members
|
| Leukaemia-associated Rho guanine nucleotide exchange factor (LARG) plays an agonist specific role in platelet function through RhoA activation
Thrombosis and Haemostasis
Leukemia-Associated RhoGEF (LARG) is highly expressed in platelets, which are essential for maintaining normal haemostasis. The authors studied the function of LARG in murine and human megakaryocytes and platelets with Larg knockout (KO), shRNA-mediated knockdown and small molecule-mediated inhibition. Read more Endothelial exocytosis of angiopoietin-2 resulting from CCM3 deficiency contributes to cerebral cavernous malformation
Nature Medicine
Cerebral cavernous malformations (CCMs) are vascular malformations that affect the central nervous system and result in cerebral hemorrhage, seizure and stroke. CCMs arise from loss-of-function mutations in one of three genes: KRIT1 (also known as CCM1), CCM2 or PDCD10 (also known as CCM3). PDCD10 mutations in humans often result in a more severe form of the disease relative to mutations in the other two CCM genes, and PDCD10-knockout mice show severe defects, the mechanistic basis for which is unclear. Read more |
|
Collaborating Societies at the IVBM
|
|
Download the IVBM Mobile App
|
Stay up to date on the meeting - download the app for your iOS or Android device.
From the app stores, search NAVBO Events or scan the appropriate QR code:
Please note - more information will continue to be added
|
|
|
